IEQ Capital’s Anavex Life Sciences AVXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$41.7K Sell
20,649
-93,599
-82% -$259K ﹤0.01% 1921
2026
Q2
$296K Buy
114,248
+45,147
+65% +$134K ﹤0.01% 1647
2026
Q1
$212K Buy
+69,101
New +$299K ﹤0.01% 1666

Other funds holding AVXL

IEQ Capital's AVXL Position: Q3 2026 in Review

IEQ Capital reduced its Anavex Life Sciences (AVXL) stake by 82% in Q3 2026, selling an estimated $259K and leaving 20,649 shares worth $41.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1921.

IEQ Capital first reported a position in AVXL in Q1 2026 and has held it in 3 quarters since. The position peaked at $296K in Q2 2026. 166 funds tracked by Wall St. Rank hold AVXL as of Q3 2026.

  • IEQ Capital held 20,649 shares of Anavex Life Sciences worth $41.7K as of Q3 2026.
  • IEQ Capital sold 93,599 Anavex Life Sciences shares in Q3 2026, an estimated $259K.
  • Anavex Life Sciences made up ﹤0.01% of IEQ Capital's portfolio in Q3 2026, its #1921 holding.
  • IEQ Capital first reported a position in Anavex Life Sciences in Q1 2026 and has held it in 3 quarters since.
  • IEQ Capital's Anavex Life Sciences position peaked at $296K in Q2 2026.
  • 166 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q3 2026.

Based on IEQ Capital's 13F filing for Q3 2026, filed 10 Nov 2026.